Our quality assurance program operates in compliance with GLP standards. As such, it provides assurance that the protocols, studies and reports are carried out in compliance with expectations of FDA and other regulatory agencies.
To see the guidelines and standards followed by MicaGenix as spelled by their respective regulatory agencies, you may visit the following links:
- OECD Guidelines for testing of new chemicals
- OECD #423 Acute Oral Toxicity—Acute Toxic Class Method
- OECD AMES Guideline #471
- OECD In Vivo Mammalian Micronucleus Test #474
- OECD Chromosome Aberration Guideline # 473
- OECD In Vitro Micronucleus #487 DRAFT GUIDELINE
- FDA Center for Drug Evaluation (CDER Guidance on Genetic toxicology)
- GLP 21 CFR Part 58 1987 Good Laboratory Practice Regulations
